GRM5 and Dyskinesia: Further supporting a role of mGluR5 in L-DOPA-induced dyskinesias, it was recently reported that mGluR5 binding was increased in the putamen and pallidum of dyskinetic MPTP-treated primates, while mGluR5 binding was normalized when dyskinesias were prevented by NMDA receptor blockade [241].